Skip to main content

Table 2 Multivariable Cox regression of systemic recurrence-free survival and breast cancer–specific survival in operable breast cancer patients (n = 191) according to pre-operative DTC status after median 15.3 years of follow-up

From: Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients

ParameterHazard ratio95% CIp-value
Systemic recurrence-free survivalPre-operative DTC status (pos. vs neg.)2.941.385–6.3390.006
Post-operative DTC status (pos. vs neg.)2.871.335–6.1840.007
MAI status (high vs low)2.651.352–5.1860.005
Breast cancer–specific survivalPre-operative DTC status (pos. vs neg.)3.481.389–8.7230.008
Post-operative DTC status (pos. vs neg.)2.671.033–6.8850.043
MAI status (high vs low.)4.351.916–9.874< 0.001
  1. Only results from backward stepwise selection of variables are presented. Results from overall survival are not presented.
  2. p-value ≤0.05 are in bold